SUBSCRIBE
SUBSCRIBE
News   Business

EpiCept Corporation’s Board of Directors Appoints New Independent Member

April 28, 2011 | 
1 min read
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced today the appointment of Keith L. Brownlie, former partner of Ernst & Young LLP, to its Board of Directors.
People
MORE ON THIS TOPIC
Isometric businessman tightrope walker is on the rope. Teetering on the cable. Business challenge and risk concept. Simple minimal design. Trendy style graphic. Flat vector illustration.
Business
Phase III Fail Forces Neuphoria Into Strategic Review—With One Investor Offering a Takeover
November 12, 2025
 · 
1 min read
 · 
Tristan Manalac
Silver Spring, MD, USA 11/10/2020: Exterior view of the headquarters of US Food and Drug Administration (FDA). This federal agency approves medications, vaccines and food additives for human use.
FDA
FDA Stalwart Pazdur Named Tidmarsh’s Replacement as CDER Director
November 11, 2025
 · 
1 min read
 · 
Heather McKenzie
Illustration showing large scissors cutting employees in half
Layoffs
Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset
November 10, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Catalent’s Announced Cuts in Maryland This Year Now Total Over 400 Employees
November 10, 2025
 · 
78 min read
 · 
BioSpace Editorial Staff